Lijuan Deng

4.9k citations

108 papers · 3.3k indexed · 2 hit papers · h-index 29

Co-authors: Dongmei Zhang Wen‐Cai Ye Jiaxu Chen Minfeng Chen Caixia Sun Qiao Sun Zhen Li Chongjun Zhao
Topics: Lymphoma Diagnosis and Treatment (27 papers)Viral-associated cancers and disorders (11 papers)MicroRNA in disease regulation (7 papers)
Cited by: Biological Psychiatry Cancer Research Toxicology
Journals: Journal of the American Statistical Association Blood PLoS ONE
Partner nations: China United States Ethiopia

In The Last Decade

Lijuan Deng

104 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

One-pot solventless preparation of PEGylated black phosphorus nanoparticles for photoacoustic imaging and photothermal therapy of cancer

2016 419 citations Lijuan Deng et al. profile →
m6A modification: recent advances, anticancer targeted drug discovery and beyond

2022 252 citations Lijuan Deng, Minfeng Chen et al. Molecular Cancer profile →

Peers

Countries citing papers authored by Lijuan Deng

Since Specialization

Citations

This map shows the geographic impact of Lijuan Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijuan Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijuan Deng more than expected).

Fields of papers citing papers by Lijuan Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijuan Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijuan Deng. The network helps show where Lijuan Deng may publish in the future.

Co-authorship network of co-authors of Lijuan Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Lijuan Deng. A scholar is included among the top collaborators of Lijuan Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijuan Deng. Lijuan Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Erianin inhibits the proliferation and stemness of pancreatic cancer cells by interacting with MEK1/2 2025 ·Biochemical Pharmacology ·(unknown),Sheng Zhou,Fangyuan Yang,(unknown),Jiaxin Luo,Fei Xie,Dongdong Liu,Yuhe Lei,Lijuan Deng	1
2	Xiaoyaosan improves depression-like behaviours in mice with post-stroke depression by modulating gut microbiota and microbial metabolism and regulating P2X7R/NLRP3 inflammasome 2025 ·Phytomedicine ·(unknown),(unknown),(unknown),Nana Ding,(unknown),Jingbo Hu,Jun Tong,(unknown),Lijuan Deng,Xiang Luo,Wenzhi Hao,Jiaxu Chen	1
3	Chitosan inhibits vascular intimal hyperplasia via LINC01615/MIR-185-5p/PIK3R2 signaling pathway 2023 ·Gene ·Yan Yan,Qian Wu,Jinhong Li,Xin Wei,Jun Xiao,Yang Liu,An Xie,Li Zhang,Wenjuan Mei,(unknown),(unknown),Dan Wen,Lijuan Deng,Linfeng Zheng	1
4	Mutation divergence over space in tumour expansion 2023 ·Journal of The Royal Society Interface ·Haiyang Li,Zixuan Yang,(unknown),Lijuan Deng,(unknown),Xing Fu,(unknown),Di Gu,Benjamin Werner,Weini Huang	2
5	Xiaoyaosan ameliorates depressive-like behavior and susceptibility to glucose intolerance in rat: involvement of LepR-STAT3/PI3K pathway in hypothalamic arcuate nucleus 2023 ·BMC Complementary Medicine and Therapies ·Wenqi Qiu,Qian Wu,Kaiwen Zhang,(unknown),Kairui Tang,Naijun Yuan,Lijuan Deng,Man-Si Wu,Ying Zhang,(unknown),Qingyu Ma,Xiaojuan Li,Jiaxu Chen	8
6	Noninvasive Strategies for the Treatment of Tiny Liver Cancer: Integrating Photothermal Therapy and Multimodality Imaging EpCAM-Guided Nanoparticles 2023 ·ACS Applied Materials & Interfaces ·Maohua Huang,Ming Qi,Hongyan Yang,Zhi Peng,(unknown),(unknown),(unknown),Lijuan Deng,(unknown)	5
7	Periplocin inhibits hepatocellular carcinoma progression and reduces the recruitment of MDSCs through AKT/NF-κB pathway 2023 ·Life Sciences ·Jiapeng Lin,Maohua Huang,(unknown),Lei Chen,Yuhe Lei,Yuqing Huang,Ming Qi,(unknown),(unknown),(unknown),(unknown),Junshan Liu,Min Hu,Minfeng Chen,Wen‐Cai Ye,Yueyue Chen,Lijuan Deng	11
8	Model for Predicting Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Discussion of Prophylaxis Measures 2023 ·World Neurosurgery ·(unknown),Yanfei Liu,(unknown),Lan Mi,Lijuan Deng,Jun Zhu,(unknown)	1
9	m6A modification: recent advances, anticancer targeted drug discovery and beyondbreakdown → 2022 ·Molecular Cancer ·Lijuan Deng,(unknown),(unknown),Minfeng Chen,Ming Qi,Wen-Yu Lyu,Qi Qi,Amit K. Tiwari,Jiaxu Chen,Dongmei Zhang,Zhe‐Sheng Chen	252
10	New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects 2022 ·Drug Resistance Updates ·Maohua Huang,(unknown),Chenran Wang,Lijuan Deng,Minfeng Chen,Yehuda G. Assaraf,Zhe‐Sheng Chen,Wen‐Cai Ye,Dongmei Zhang	101
11	Emerging roles of long non-coding RNA in depression 2022 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Wenzhi Hao,Qian Chen,Lu Wang,Gabriel Tao,Hua Gan,Lijuan Deng,Junqing Huang,Jiaxu Chen	26
12	Targeting FAPα-expressing tumor-associated mesenchymal stromal cells inhibits triple-negative breast cancer pulmonary metastasis 2021 ·Cancer Letters ·Zheng‐Xiang Li,Minfeng Chen,(unknown),Jun Tang,Lijuan Deng,Qing Wen,Maohua Huang,(unknown),(unknown),Wen‐Cai Ye,Dongmei Zhang	19
13	Leukaemia cutis as a specific skin involvement in chronic myelomonocytic leukaemia and review of the literature 2020 ·Translational Cancer Research ·(unknown),(unknown),Lijuan Deng,(unknown),Bei Liu	6
14	Ginsenoside F1 promotes angiogenesis by activating the IGF-1/IGF1R pathway 2019 ·Pharmacological Research ·Jiayan Zhang,Mingqun Liu,Maohua Huang,Minfeng Chen,Dong Zhang,(unknown),(unknown),Lijuan Deng,Yinghui Peng,Xin Wu,(unknown),Wen‐Cai Ye,Dongmei Zhang	82
15	Xiaoyaosan improves depressive-like behavior in rats with chronic immobilization stress through modulation of the gut microbiota 2019 ·Biomedicine & Pharmacotherapy ·Huizheng Zhu,Yudan Liang,Qingyu Ma,Wenzhi Hao,Xiaojuan Li,Man-Si Wu,Lijuan Deng,(unknown),Jiaxu Chen	141
16	Anti-tumor effects and 3D-quantitative structure-activity relationship analysis of bufadienolides from toad venom 2019 ·Fitoterapia ·Jun-Shan Liu,Lijuan Deng,Hai‐Yan Tian,Zhixiong Ruan,Huihui Cao,Wen‐Cai Ye,Dongmei Zhang,Zhi‐Ling Yu	22
17	Outcome and Prospective Factor Analysis of High-dose Therapy Combined with Autologous Peripheral Blood Stem Cell Transplantation in Patients with Peripheral T-cell Lymphomas 2018 ·International Journal of Medical Sciences ·(unknown),Xiaopei Wang,Yan Xie,Weiping Liu,Chen Zhang,Lingyan Ping,Zhitao Ying,Lijuan Deng,Wen Zheng,Ningjing Lin,Meifeng Tu,Yuqin Song,Jun Zhu	11
18	Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In Vitro and In Vivo 2015 ·Scientific Reports ·Zhenjian Zhuo,Jianyang Hu,Xiaolin Yang,(unknown),Xueping Lei,Lijuan Deng,Nan Yao,(unknown),Zhe‐Sheng Chen,Wen‐Cai Ye,Dongmei Zhang	87
19	[Clinical characteristics and prognosis analysis of patients with LMP-1 positive Hodgkin's lymphoma after EBV infection]. 2014 ·PubMed ·Lingyan Ping,Ning Ding,Yunfei Shi,(unknown),Wen Zheng,(unknown),Xiaopei Wang,Meifeng Tu,Ningjing Lin,Zhitao Ying,Weiping Liu,Lijuan Deng,Zhan Chen,Le Tian,Lixia Feng,Yuqing Song,(unknown)	4
20	FCGR3A 158V/F Polymorphism and Response to Frontline R-CHOP Therapy in Diffuse Large B-Cell Lymphoma 2014 ·DNA and Cell Biology ·Fen Liu,Huirong Ding,Xuan Jin,Ning Ding,Lijuan Deng,Yan He,Jun Zhu,Yuqin Song	13

About Lijuan Deng

Lijuan Deng is a scholar working on Biological Psychiatry, Toxicology and Pathology and Forensic Medicine, having authored 108 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (27 papers), Viral-associated cancers and disorders (11 papers) and MicroRNA in disease regulation (7 papers). The work is most often cited by research in Biological Psychiatry (147 citations), Cancer Research (499 citations) and Toxicology (106 citations). Lijuan Deng has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Dongmei Zhang, Wen‐Cai Ye, Jiaxu Chen, Minfeng Chen, Caixia Sun, Qiao Sun, Zhen Li, Chongjun Zhao, Ming Qi and Ling Wen. Their work appears in journals such as Journal of the American Statistical Association, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact